| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 152,672 | 154,566 | 126,182 | | Cost of Revenue | 102,497 | 106,897 | 85,196 | | | Gross Profit | 50,175 | 47,669 | 40,986 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 44,060 | 42,682 | 38,967 | | Non Recurring | 5,916 |
-
| (231) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 199 | 4,987 | 2,250 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 748 | 908 | (14,511) | | Earnings Before Interest And Taxes | 947 | 5,895 | (12,261) | | Interest Expense | 14,164 | 12,033 | 12,476 | | Income Before Tax | (13,217) | (6,138) | (24,737) | | Income Tax Expense | 1,894 | 1,834 | 1,173 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,111) | (7,972) | (25,910) | | | Non-recurring Events | | Discontinued Operations |
-
| (712) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,111) | (8,684) | (25,910) | | Preferred Stock And Other Adjustments | (3,350) | (2,656) |
-
| | | Net Income Applicable To Common Shares | ($18,461) | ($11,340) | ($25,910) |
|
0.29% Nasdaq 
Income Statement
